GLUT1 to 5 & SGLT1 expression in thyroid-hormone-treated Caco-2 cells.
Matosin
M
M
Unité 178 de l'INSERM, Villejuif, France.
Allison
G G
GG
Ilundain
A A
AA
Shirazi-Beechey
S P
SP
Brot-Laroche
E
E
D018938:Caco-2 Cells; D002454:Cell Differentiation; D002455:Cell Division; D005947:Glucose / Q000378:metabolism; D051272:Glucose Transporter Type 1; D051273:Glucose Transporter Type 2; D051274:Glucose Transporter Type 3; D051275:Glucose Transporter Type 4; D051296:Glucose Transporter Type 5; D006019:Glycolysis / Q000187:drug effects; D006801:Humans; D008562:Membrane Glycoproteins / Q000096:biosynthesis*; D009004:Monosaccharide Transport Proteins / Q000096:biosynthesis*; D009124:Muscle Proteins; D009419:Nerve Tissue Proteins; D012964:Sodium / Q000378:metabolism; D051269:Sodium-Glucose Transporter 1; D014284:Triiodothyronine / Q000494:pharmacology*
D051272:Glucose Transporter Type 1; D051273:Glucose Transporter Type 2; D051274:Glucose Transporter Type 3; D051275:Glucose Transporter Type 4; D051296:Glucose Transporter Type 5; D008562:Membrane Glycoproteins; D009004:Monosaccharide Transport Proteins; D009124:Muscle Proteins; D009419:Nerve Tissue Proteins; C495677:SLC2A1 protein, human; C495687:SLC2A3 protein, human; C495692:SLC2A4 protein, human; C495674:SLC5A1 protein, human; D051269:Sodium-Glucose Transporter 1; D014284:Triiodothyronine; D012964:Sodium; D005947:Glucose